anmelden
SMIM
2.966,61
PKT
-9,72
PKT
-0,33
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMIM-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.05.12 | PSP Swiss Property hold | Vontobel Research | |
| 10.05.12 | Straumann hold | Vontobel Research | |
| 09.05.12 | Adecco SA buy | ING | |
| 09.05.12 | Swiss Prime Site hold | Vontobel Research | |
| 08.05.12 | Adecco SA buy | Sarasin Research | |
| 08.05.12 | Adecco SA buy | Vontobel Research | |
| 07.05.12 | Roche buy | Vontobel Research | |
| 04.05.12 | Adecco SA outperform | Exane-BNP Paribas SA | |
| 04.05.12 | Clariant neutral | Exane-BNP Paribas SA | |
| 04.05.12 | Clariant neutral | HSBC | |
| 04.05.12 | Clariant buy | Vontobel Research | |
| 04.05.12 | Clariant sell | Société Générale Group S.A. (SG) | |
| 03.05.12 | Clariant buy | Sarasin Research | |
| 03.05.12 | Avolta (ex Dufry) hold | Vontobel Research | |
| 03.05.12 | Clariant buy | Vontobel Research | |
| 02.05.12 | Clariant buy | Vontobel Research | |
| 27.04.12 | ams-OSRAM kaufen | Erste Bank AG | |
| 27.04.12 | SGS SA buy | Vontobel Research | |
| 26.04.12 | Straumann hold | Vontobel Research | |
| 25.04.12 | Temenos equal-weight | Morgan Stanley | |
| 25.04.12 | Lindt underperform | Cheuvreux SA | |
| 25.04.12 | ams-OSRAM buy | Erste Group Bank | |
| 25.04.12 | Temenos buy | Vontobel Research | |
| 24.04.12 | ams-OSRAM buy | Vontobel Research | |
| 19.04.12 | Schindler buy | Sarasin Research | |
| 16.04.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 13.04.12 | EMS-CHEMIE buy | Sarasin Research | |
| 13.04.12 | Roche outperform | Exane-BNP Paribas SA | |
| 12.04.12 | Roche outperform | Cheuvreux SA | |
| 12.04.12 | Swatch (I) buy | Sarasin Research | |
| 11.04.12 | Roche neutral | Nomura | |
| 10.04.12 | Clariant hold | Deutsche Bank AG | |
| 05.04.12 | Roche outperform | Credit Suisse Group | |
| 04.04.12 | Barry Callebaut sell | Société Générale Group S.A. (SG) | |
| 03.04.12 | Clariant neutral | Nomura | |
| 03.04.12 | Julius Bär equal-weight | Morgan Stanley | |
| 02.04.12 | Barry Callebaut neutral | Sarasin Research | |
| 30.03.12 | Roche neutral | WestLB AG | |
| 30.03.12 | Roche outperform | Exane-BNP Paribas SA | |
| 30.03.12 | Barry Callebaut sell | Société Générale Group S.A. (SG) |